Skip to main content

Exicure, Inc.

XCUR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001698530

No open-market purchases or sales by Exicure, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $306.0K in total; no superinvestor holds it.

Superinvestors holding XCUR, Q2 2026

See all superinvestors

No superinvestor reported holding XCUR in Q2 2026.